エピソード

  • ICT Ep21: Everything but the Kitchen Sink!
    2024/11/19

    In this episode of Innovating Clinical Trials, Liam Eves and Ted Trafford explore the challenges of recruitment and enrollment in clinical trials, comparing the current approach to "packing everything but the kitchen sink." They critique the overreliance on central advertising campaigns and highlight missed opportunities to address foundational issues like protocol design, site relationships, and storytelling.

    Ted advocates for simplifying protocols and creating a dedicated VP of Enrollment role to optimize trials for faster delivery without compromising data integrity. Liam emphasizes the underutilized power of storytelling, showing how a compelling narrative about a study or sponsor can transform site engagement and motivation.

    The discussion concludes with a call for long-term solutions to systemic enrollment issues, moving beyond the short-term study-by-study approach. Packed with practical insights and creative ideas, this episode challenges listeners to rethink clinical trial recruitment and the importance of strong, relatable narratives in building lasting partnerships with sites and patients.

    続きを読む 一部表示
    13 分
  • ICT Ep20: New ways of thinking about trial delivery
    2024/11/19

    In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford delve into the nuanced frameworks behind effective clinical trial delivery. Liam introduces a proprietary system he has been refining for over 17 years, which leverages four critical lenses: medical/scientific/regulatory, operational/logistics, behavioral science, and leadership. These frameworks aim to streamline trial delivery, reduce costs, and optimize outcomes.

    The conversation highlights how simplifying protocols and fostering early communication with regulatory bodies like the FDA can speed up trials and save resources. The discussion also explores often-overlooked aspects like the psychological dynamics of trial teams and participants, emphasizing the importance of motivation, team structure, and tailored patient engagement.

    Finally, the episode underscores the significance of strong leadership in navigating inevitable challenges and ensuring cohesive execution. Packed with insights and practical strategies, this episode offers a fresh perspective on clinical trial delivery, blending science, psychology, and operational excellence.

    続きを読む 一部表示
    16 分
  • ICT Ep19: The World of Site Startup in Clinical Trials
    2024/11/19

    In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford dive into the complex and often chaotic world of site startup in clinical trials. Using a creative metaphor of a horse race, they vividly illustrate the hurdles and unpredictable challenges faced during site activation, from regulatory documentation delays to contract negotiations stumbling out of the gate.

    Liam and Ted explore the critical impact of poor planning, misaligned communication, and unreliable vendors on trial timelines, emphasizing how these factors can derail even the most promising studies. They also discuss actionable solutions, such as adopting more realistic startup timelines, improving communication with sites and patients, and streamlining access to necessary resources and technology.

    With a mix of humor, insight, and practical advice, this episode is a must-listen for anyone looking to better understand the intricacies of site startup and how to overcome its challenges.

    続きを読む 一部表示
    12 分
  • ICT Ep18: Advice for Startups in the Clinical Trial Space with Selin Kurnaz (Part 3 of 3)
    2024/10/09

    In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford are joined by Selin, CEO and founder of Massive Bio, to discuss the challenges and opportunities for startups in the clinical trial space. Selin shares her expertise on what it takes to succeed in this highly complex and regulated industry. We provide some valuable advice for startup CEOs, emphasizing the importance of understanding the true pain points within pharma, focusing on solving critical problems, and knowing who will pay for the solution. We also highlightsthe difficulties startups face, from long revenue cycles to navigating the unique challenges of working with pharmaceutical companies, and stresses the need for resilience and dedication to overcome these hurdles.

    続きを読む 一部表示
    17 分
  • ICT Ep17: Exploring Enrollment Gaps in Oncology Trials with Selin Kurnaz (Part 2 of 3)
    2024/10/09

    In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford continue their discussion with Selin Kurnaz, CEO and founder of Massive Bio, an AI-powered platform that connects cancer patients with clinical trials. The conversation centers around the critical challenges in oncology trial enrollment, from recruitment failures to the operational difficulties encountered in the "Last Mile." We discuss the need for transparency, education, and a rethinking of traditional clinical trial processes. Selin discusses the complexity of site selection, prescreening, and patient identification, highlighting that the current system often overlooks the operational steps that are crucial for successful trial participation.

    続きを読む 一部表示
    17 分
  • ICT Ep16: Revolutionizing Cancer Trial Enrollment with Selin Kurnaz (Part 1 of 3)
    2024/10/09

    In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford are joined by Selin Kurnaz, CEO and founder of Massive Bio, an AI-driven platform designed to connect cancer patients with clinical trials.

    Our conversation dives deep into the challenges of patient awareness, access, and logistical hurdles in trial enrollment. Selin shares how her personal experience with her uncle’s cancer diagnosis led to the creation of Massive Bio and her mission to streamline trial enrollment using technology.

    We discuss the "Last Mile" problem and walk through how combining technological scale with personalized concierge services can help patients not only find relevant trials but also overcome the logistical and financial barriers that can prevent participation. With insights into the complexities of the clinical trial landscape, the discussion highlights the critical steps needed to bridge the gap between patients and life-saving treatments.

    続きを読む 一部表示
    17 分
  • ICT Ep15: Q2'24 The quarterly recap with Joel White (Part 3 of 3)
    2024/09/08

    Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom.

    In today's session we chat with Joel White from Marketcap Consulting about the financial performance of the clinical development space. In the final part of our 3 part discussion we talk through book to bill ratios, find out what is concerning Joel with the market and dive deeper into the Walgreens and BARDA agreement.

    続きを読む 一部表示
    18 分
  • ICT Ep14: Q2'24 The quarterly recap with Joel White (Part 2 of 3)
    2024/09/08

    Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom.

    In this session we continue our discussion with Joel White from Marketcap Consulting about the financial performance of the clinical development space. We find out what Joel is bullish about and dive into the pre-clinical space.

    Stay tuned for part 3.

    続きを読む 一部表示
    16 分